The Early Outcomes of Candidates with Portopulmonary Hypertension After Liver Transplantation

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2018 Jun 9

PMID 29879915

Citations 3

Authors

Bingsong Huang

Yi Shi

Jun Liu

Paul M Schroder

Suxiong Deng

Maogen Chen

Jun Li

Yi Ma

Ronghai Deng

Affiliations

Soon will be listed here.

Abstract

Background: Portopulmonary hypertension (PPH) was once regarded as a contraindicaton to liver transplantation (LT). However, growing evidence has indicated that PPH patients undergoing LT may show similar outcomes compared to those without PPH, and researchers have recommended it not be an absolute contraindication. Given this controversy, we aimed to identify and review the current evidence on this topic and to provide a comparison of the outcomes after LT between candidates with PPH and those without.

Methods: We systematically searched the MEDLINE, EMBASE and Cochrane Library databases for all studies that compared the outcomes of PPH patients and those without PPH after LT. All studies reporting outcomes of PPH patients versus those without PPH (Control) were further considered for inclusion in this meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to compare the pooled data between PPH and Control groups.

Results: Eleven retrospective trials and one prospective, randomized, controlled trial, involving 37,686 transplant recipients were included. The PPH patients had increased 1-year mortality with an OR of 1.59 (95% CI = 1.26-2.01, P = 0.0001) compared to the control group. There was no significant difference in graft loss and 30-day mortality after LT between the two groups.

Conclusions: Patients with PPH who underwent LT had increased 1-year mortality compared to those without PPH, while graft loss and 30-day mortality were similar. Nevertheless, LT may be a reasonable therapeutic option for some patients with PPH, but further studies are needed to identify those select patients with PPH who would benefit most from LT.

Citing Articles

Utility of transesophageal echocardiography during orthotopic liver transplantation: A narrative review.

Hansebout C, Desai T, Dhir A Ann Card Anaesth. 2023; 26(4):367-379.

PMID: 37861569 PMC: 10691562. DOI: 10.4103/aca.aca_186_22.

LTSI Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients.

Singh S, Shrivastava P, Agarwal A, Nandakumar K, Nasa V, Premkumar G J Clin Exp Hepatol. 2023; 13(3):523-531.

PMID: 37250889 PMC: 10213854. DOI: 10.1016/j.jceh.2022.12.012.

Pulmonary manifestations of chronic liver disease: a comprehensive review.

Soulaidopoulos S, Goulis I, Cholongitas E Ann Gastroenterol. 2020; 33(3):237-249.

PMID: 32382226 PMC: 7196609. DOI: 10.20524/aog.2020.0474.

References

Ford H, Aris R, Andreoni K . Screening for portopulmonary hypertension with transthoracic echocardiography: implications for early mortality associated with liver transplantation. Am J Respir Crit Care Med. 2009; 180(4):378. DOI: 10.1164/ajrccm.180.4.378. View

Krowka M, Mandell M, Ramsay M, Kawut S, Fallon M, Manzarbeitia C . Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004; 10(2):174-82. DOI: 10.1002/lt.20016. View

Krowka M, Fallon M, Kawut S, Fuhrmann V, Heimbach J, Ramsay M . International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016; 100(7):1440-52. DOI: 10.1097/TP.0000000000001229. View

Yassen A, Elsarraf W, Elsadany M, Elshobari M, Salah T, Sultan A . The impact of portopulmonary hypertension on intraoperative right ventricular function of living donor liver transplant recipients. Anesth Analg. 2012; 115(3):689-93. DOI: 10.1213/ANE.0b013e318261f6d9. View

Taura P, Garcia-Valdecasas J, Beltran J, Izquierdo E, Navasa M, Mas A . Moderate primary pulmonary hypertension in patients undergoing liver transplantation. Anesth Analg. 1996; 83(4):675-80. DOI: 10.1097/00000539-199610000-00003. View

Rajaram P, Parekh A, Fisher M, Kempker J, Subramanian R . Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience. Transplant Proc. 2017; 49(2):338-343. DOI: 10.1016/j.transproceed.2016.12.006. View

Herve P, Le Pavec J, Sztrymf B, Decante B, Savale L, Sitbon O . Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol. 2007; 21(1):141-59. DOI: 10.1016/j.bpg.2006.07.011. View

Murray K, Carithers Jr R . AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005; 41(6):1407-32. DOI: 10.1002/hep.20704. View

Starkel P, Vera A, Gunson B, Mutimer D . Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl. 2002; 8(4):382-8. DOI: 10.1053/jlts.2002.31343. View

10.

Veloso C, Boin I, Dragosavac D, Leonardi L, Figueiredo L, Araujo S . Retrospective analysis of patients who developed pulmonary hypertension during the early postoperative period after liver transplantation. Transplant Proc. 2004; 36(4):938-40. DOI: 10.1016/j.transproceed.2004.04.006. View

11.

Savas Bozbas S, Eroglu S, Eyuboglu F, Moray G, Haberal M . Pulmonary Hypertension Improves After Orthotopic Liver Transplant in Patients With Chronic Liver Disease. Exp Clin Transplant. 2015; 13 Suppl 3:115-9. DOI: 10.6002/ect.tdtd2015.P65. View

12.

Hoeper M, Krowka M, Strassburg C . Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004; 363(9419):1461-8. DOI: 10.1016/S0140-6736(04)16107-2. View

13.

DeMartino E, Cartin-Ceba R, Findlay J, Heimbach J, Krowka M . Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation. Transplantation. 2016; 101(1):101-106. DOI: 10.1097/TP.0000000000001517. View

14.

Fukazawa K, Poliac L, Pretto E . Rapid assessment and safe management of severe pulmonary hypertension with milrinone during orthotopic liver transplantation. Clin Transplant. 2009; 24(4):515-9. DOI: 10.1111/j.1399-0012.2009.01119.x. View

15.

Lentine K, Villines T, Axelrod D, Kaviratne S, Weir M, Costa S . Evaluation and Management of Pulmonary Hypertension in Kidney Transplant Candidates and Recipients: Concepts and Controversies. Transplantation. 2016; 101(1):166-181. DOI: 10.1097/TP.0000000000001043. View

16.

Iqbal C, Krowka M, Pham T, Freese D, El Youssef M, Ishitani M . Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. J Pediatr Surg. 2008; 43(10):1813-20. DOI: 10.1016/j.jpedsurg.2008.04.002. View

17.

Koch D, Caplan M, Reuben A . Pulmonary hypertension after liver transplantation: case presentation and review of the literature. Liver Transpl. 2009; 15(4):407-12. DOI: 10.1002/lt.21713. View

18.

Saner F, Nadalin S, Pavlakovic G, Gu Y, Olde Damink S, Gensicke J . Portopulmonary hypertension in the early phase following liver transplantation. Transplantation. 2006; 82(7):887-91. DOI: 10.1097/01.tp.0000235520.37189.fe. View

19.

Warnaar N, Molenaar I, Colquhoun S, Slooff M, Sherwani S, De Wolf A . Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Haemost. 2007; 6(2):297-302. DOI: 10.1111/j.1538-7836.2008.02831.x. View

20.

Raevens S, Colle I, Reyntjens K, Geerts A, Berrevoet F, Rogiers X . Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl. 2013; 19(6):602-10. DOI: 10.1002/lt.23649. View